Hikma Seeks Rehearing In Vascepa Skinny-Label Case

Claims Panel Decision To Reopen Case Contradicts Precedent And Will Chill Competition

 
• By Dave Wallace
  
US Court of Appeals for the Federal Circuit sign
Hikma has asked for an “en banc” panel rehearing • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin